MG
IOBT

Marex Group’s IO Biotech IOBT Stock Holding History

Marex Group’s Portfolio IOBT Stock Details IOBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-45,000
Closed -$62.5K – 927
2025
Q2 		$62.5K Hold
45,000
– – ﹤0.01% 588
2025
Q1 		$49K Hold
45,000
– – ﹤0.01% 640
2024
Q4 		$41.4K Hold
45,000
– – ﹤0.01% 645
2024
Q3 		$47.3K Hold
45,000
– – ﹤0.01% 563
2024
Q2 		$52.6K Hold
45,000
– – ﹤0.01% 591
2024
Q1 		$78.8K Buy
+45,000
New +$78.1K ﹤0.01% 436

Other funds holding IOBT

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Marex Group's IOBT Position: Q3 2025 in Review

Marex Group sold out of IO Biotech (IOBT) in Q3 2025, closing a stake of 45,000 shares — an estimated $62.5K sold.

Marex Group first reported a position in IOBT in Q1 2024 and held it in 6 quarters. The position peaked at $78.8K in Q1 2024. 21 funds tracked by Wall St. Rank hold IOBT as of Q3 2025.

  • Marex Group reported no remaining IO Biotech position as of Q3 2025 after selling out during the quarter.
  • Marex Group sold 45,000 IO Biotech shares in Q3 2025, an estimated $62.5K.
  • Marex Group first reported a position in IO Biotech in Q1 2024 and held it in 6 quarters.
  • Marex Group's IO Biotech position peaked at $78.8K in Q1 2024.
  • 21 funds tracked by Wall St. Rank held IO Biotech as of Q3 2025.

Based on Marex Group's 13F filing for Q3 2025, filed 14 Nov 2025.